Searched for
PFIZER TARGET PRICE
Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...- Ahead of Market: 10 things that will decide stock market action on FridayIndian equities ended largely unchanged as West Asia tensions tempered risk appetite. Broader markets outperformed despite recent correctio...
- US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...
- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- Eli Lilly brings monthly Alzheimer's therapy donanemab to India at ₹91,688 per vialEli Lilly is making Alzheimer's a major focus for its future innovations. The company is also expanding its specialty medicine offerings in...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- US stock market today: Why is Nasdaq crashing big today? Dow and S&P 500 slip as Nasdaq plunges over 300 points - Nvidia, AMD, Intel lead tech lossesUS stock market today: Nasdaq crashing big today as Dow Jones and S&P 500 also slip. The US stock market today shows a sharp shift. The Nas...
- US Stocks | Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats upKailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....
- Pfizer shares jump 8% on Medicaid deal with TrumpPfizer shares surged after the US drugmaker agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration...
- Hold Pfizer, target price Rs 3830: ICICI DirectPfizer, incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 17452.53 Crore) operating in Pharmaceuticals secto...
- Buy Pfizer, target price Rs 5250: Anand RathiPfizer, incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 20966.41 Crore) operating in Pharmaceuticals secto...
- Hold Pfizer, target price Rs 4480: ICICI DirectPfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 19287.47 Crore) operating in Pharmaceuticals ...
- Buy Pfizer, target price Rs 4620: Yes SecuritiesPfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 20049.17 Crore) operating in Pharmaceuticals ...
- Buy Pfizer, target price Rs 5314: ICICI SecuritiesPfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 20591.05 Crore) operating in Pharmaceuticals ...
- Buy Pfizer, target price Rs 6000: Yes SecuritiesPfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 25337.61 Crore) operating in Pharmaceuticals ...
- Buy Pfizer, target price Rs 5450: ICICI DirectPfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 21946.10 Crore) operating in Pharmaceuticals ...
- Buy Pfizer, price target Rs 4,340: Dharmesh ShahThe analyst suggested a stoploss at Rs 4040 .
- Centrum maintains buy on Pfizer, target price Rs 5,000Shares of Pfizer closed at Rs 4,128, up 2.5%.
- Buy Pfizer, target Rs 2900: Centrum BrokingBuy Pfizer Ltd. at a price target of Rs 2900.
- Buy Pfizer Ltd. target Rs 2035.0 : ICICI DirectBuy Pfizer Ltd. at a price target of Rs 2035.0 and a stoploss at Rs 1870 from entry point.
Load More
